New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia

被引:45
作者
Kase, H [1 ]
机构
[1] Kyowa Hakko Kogyo Co Ltd, Div Pharmaceut Res & Dev, Chiyoda Ku, Tokyo 1008185, Japan
关键词
adenosine; receptor; movement; basal ganglia; neuromodulation;
D O I
10.1271/bbb.65.1447
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is now growing interest in the functional role of adenosine A(2A) receptors. Their distribution within the brain is restricted in the basal ganglia, particularly abundant in the striatum, which are thought to play a crucial role in the control of motor behavior. Indeed, newly developed A(2A) receptor selective antagonists have a profound influence on motor functions, with anti-Parkinsonian activities in several animal models. Striatal spiny neurons serve as a major anatomical locus for the relay of cortical information flow through the basal ganglia. The GABA releasing projection neurons represent the A(2A) receptor-mediated main target of adenosine. The GABAergic synaptic neurotransmission is regulated by adenosine via A(2A) receptors on the presynaptic terminals. Blockade of this modulatory function by A(2A) antagonists could repair striatopallidal abnormal neuronal activities provoked by striatal dopamine depletion in the Parkinsonian state. A(2A) receptor antagonists provide a novel therapeutic potential for the treatment of Parkinson's disease.
引用
收藏
页码:1447 / 1457
页数:11
相关论文
共 80 条
[1]   Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist [J].
Aoyama, S ;
Kase, H ;
Borrelli, E .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5848-5852
[2]   ADENOSINE A(2A) RECEPTOR MESSENGER-RNA IS EXPRESSED BY ENKEPHALIN CELLS BUT NOT BY SOMATOSTATIN CELLS IN RAT STRIATUM - A COEXPRESSION STUDY [J].
AUGOOD, SJ ;
EMSON, PC .
MOLECULAR BRAIN RESEARCH, 1994, 22 (1-4) :204-210
[3]   PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[4]  
Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9
[5]   THE CHANGING FACE OF AUTONOMIC NEUROTRANSMISSION [J].
BURNSTOCK, G .
ACTA PHYSIOLOGICA SCANDINAVICA, 1986, 126 (01) :67-91
[6]  
Calabresi P, 1997, J NEUROSCI, V17, P4509
[7]   Acetylcholine-mediated modulation of striatal function [J].
Calabresi, P ;
Centonze, D ;
Gubellini, P ;
Pisani, A ;
Bernardi, G .
TRENDS IN NEUROSCIENCES, 2000, 23 (03) :120-126
[8]   Neostriatal mechanisms in Parkinson's disease [J].
Chase, TN ;
Oh, JD ;
Blanchet, PJ .
NEUROLOGY, 1998, 51 (02) :S30-S35
[9]  
Chergui K, 2000, J NEUROSCI, V20, P2175
[10]   N-METHYL-D-ASPARTATE-EVOKED AND NON-N-METHYL-D-ASPARTATE-EVOKED ADENOSINE RELEASE FROM RAT CORTICAL SLICES - DISTINCT PURINERGIC SOURCES AND MECHANISMS OF RELEASE [J].
CRAIG, CG ;
WHITE, TD .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (03) :1073-1080